coronary disease
Showing NaN - NaN of 14
Sensor-equipped Ultrathin Pressure Microcatheter Versus Pressure
Enrolling by invitation
- Coronary Artery Disease
- +2 more
- Randomized physiological measurements by the two systems
-
Beijing, Beijing, China
- +10 more
Oct 30, 2022
Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome Trial in China (Clopidogrel and Aspirin dual-antiplatelet
Recruiting
- Coronary Artery Disease
- +9 more
- Clopidogrel and Aspirin dual-antiplatelet therapy
- Aspirin monotherapy
-
Beijing, Beijing, China
- +108 more
Oct 25, 2022
Coronary Disease Trial in Beijing (Paclitaxel DCB, DES)
Completed
- Coronary Disease
- Paclitaxel DCB
- DES
-
Beijing, Beijing, ChinaBeijing Hospital
Mar 21, 2022
Coronary Disease Trial in Beijing (Paclitaxel DCB)
Recruiting
- Coronary Disease
- Paclitaxel DCB
-
Beijing, Beijing, ChinaBeijing Hospital
Mar 21, 2022
Coronary Disease Trial in Beijing (18F-FMPP)
Unknown status
- Coronary Disease
-
Beijing, Dongcheng, ChinaPeking union medical college hospital
Oct 21, 2020
Ischemic Heart Disease, Myocardial Ischemia, Coronary Disease Trial in Beijing (AVI® Arsenic trioxide drug eluting stent
Active, not recruiting
- Ischemic Heart Disease
- +3 more
- AVI® Arsenic trioxide drug eluting stent delivery system
- Firebird2® sirolimus eluting stent system
-
Beijing, Beijing, ChinaPeking University First Hospital
Nov 14, 2019
The FAVOR II China Study
Completed
- Coronary Artery Disease
- +7 more
- Fractional Flow Reserve (FFR)
-
Beijing, Beijing, China
- +4 more
Jul 25, 2017
Coronary Disease Trial in Beijing (Ticagrelor, Clopidogrel)
Unknown status
- Coronary Disease
-
Beijing, Beijing, ChinaFuwai hospital
Feb 8, 2017
Coronary Occlusion, Thrombosis (Stent Thrombosis), Vascular Disease Trial in Beijing, Shanghai (XIENCE V EECSS, CYPHER SELECT
Completed
- Coronary Occlusion
- +7 more
- XIENCE V EECSS
- CYPHER SELECT PLUS SECSS
-
Beijing, China
- +1 more
Jul 14, 2016
Stable Angina, Coronary Disease Trial in Beijing (Nicorandil, Standard Treatment)
Completed
- Stable Angina
- Coronary Disease
- Nicorandil
- Standard Treatment
-
Beijing, ChinaFor Locations in
Mar 15, 2016
Coronary Disease, Coronary Artery Disease, Coronary Restenosis Trial in Worldwide (XIENCE V® Everolimus Eluting Coronary Stent)
Completed
- Coronary Disease
- +2 more
- XIENCE V® Everolimus Eluting Coronary Stent
-
Salzburg, Austria
- +92 more
Oct 13, 2010
Coronary Disease Trial in Beijing (stent)
Unknown status
- Coronary Disease
- stent
-
Beijing, ChinaFuwai Hospital
Apr 29, 2009
Coronary Disease, Myocardial Infarction Trial in Beijing (Bone Marrow Stem Cell Therapy combined CABG)
Unknown status
- Coronary Disease
- Myocardial Infarction
- Bone Marrow Stem Cell Therapy combined CABG
-
Beijing, ChinaFuwai cardiovascular disease hospital
Oct 28, 2008